Impute

Chiyoda, Japan Founded: 2017 • Age: 9 yrs
AI-based app providing personalized therapy for students with autism

About Impute

Impute is a Healthcare company based in Chiyoda (Japan) founded in 2017. It operates as an AI-based app providing personalized therapy for students with autism. Impute has raised $1.3 million across 2 funding rounds from investors including i-nest capital, Arco Partners and TX Entrepreneur Partners. Its focus areas include HealthTech, Disease Self Management, Neurological Disorders and Therapy. Its competitors include Altoida, Brain in Hand, Kyo, Jade Autism and Changingday and 3 more; 4 of its 8 listed competitors have raised funding.

Company details

Impute was founded in 2017 in Chiyoda City, Japan, within the edtech sector focused on disabilities. An AI-based app is operated to deliver cognitive training for children with Autism Spectrum Disorder, ADHD, and learning disabilities. Personalized therapy programs are created using eye-tracking and body tracking technologies. Individual assessments, customized plans, reinforced learning, and discrete trial training are included among the core services.

  • Headquarters Chiyoda, Japan
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website impute.co.jp
  • Social LinkedIn X Facebook
Key Metrics
  • Total Equity Funding
    $1.3M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.3M (USD), Series A

    Jan 2022

  • Investors

Funding Insights of Impute

Impute has successfully raised a total of $1.3M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.3 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.3M
  • Total Rounds 2
  • Last Round Series A β€” $1.3M
  • Investors Count 4

All 2 funding rounds of Impute with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2022$1.3MSeries A–i-nest capital
–
Jun 2021–Seed–Arco Partners
Valuation history

4 investors in total: 4 institutional.

Investors in Impute

Impute has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include i-nest capital, Arco Partners and TX Entrepreneur Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital services are provided to support innovative startups.
–i-nestcapital.comShibuya, Japan
Venture support and investment services are provided to startups.
2016arcopartners.coTokyo, Japan
Delivers comprehensive investment solutions to support business growth and financial planning.
2009tepweb.jpKashiwa, Japan
-
–jfc.go.jp-
Premium access

Investor details for Impute

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Impute

2 people are tracked at Impute (2 in leadership).

NameRoleGroup
Hirofumi Hamanaka
Vice President Health CareLeadership
Dr. Mayank S.
AI Entrepreneur, Founder & CEOLeadership
Premium access

Complete people profiles for Impute

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Impute

3 dated milestones of Impute across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Impute is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A, of $1.3M.

Competitors of Impute

Impute has 8 listed competitors in our database, 4 of them funded. They include Altoida, Brain in Hand, Kyo, Jade Autism and Changingday, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
altoida.com2016Lucerne, Switzerland$20.3M–
Provider of a AI-based app which can predict the onset of Alzheimer's
braininhand.co.uk2009Exeter, United Kingdom$1.02M136
Assistive technology is developed for impaired executive brain functions.
kyocare.com2005San Francisco, United States–845
ABA therapy programs are delivered online for children with autism.
jadend.tech2018Vitoria, Brazil––
Educational solutions for children with autism spectrum disorder are developed.
changingday.com2008Glasgow, United Kingdom$945,3869
VR-based solutions for autism treatment via social simulations are provided.
getpalbud.com2021–––
Wearable device for autism management
asd.ai2020Red Oak, United States$1M–
AI-based mobile app for children with autism
siricatx.com2022San Francisco, United States––
Develops digital therapy for ASD using VR, robotics, and physical exercise.
Premium access

Detailed competitors of Impute

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Impute

The website of Impute (impute.co.jp) receives about 3.1K visits a month.

  • Monthly visits
    3.1K

    ▲ 3.4% vs previous month

Top companies in Health Monitoring & Wearables

10 companies that operate in the same segment as Impute (Health Monitoring & Wearables), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Smart fitness equipment and streaming platforms are provided.
2011New York, New York, United StatesUSD 995.53 MUSD 2.45 B2,894
Connected devices for health, sleep, and activity monitoring are developed.
2008Moulineaux, Seine-maritime, FranceUSD 93.83 M––
Internet first brand offering wearable breast pumps
2013London, England, United KingdomUSD 157.63 M––
Metabolic health is tracked via devices and fitness platforms.
2019Bengaluru, Karnataka, IndiaUSD 163.28 MUSD 65.48 M274
Health-tracking smart rings and biosensors are developed for biometric monitoring.
2013Oulu, North Ostrobothnia, FinlandUSD 1.32 BUSD 398.5 M1,632
Wearable glucose monitoring patches are provided for real-time data tracking.
1999San Diego, California, United StatesUSD 52.5 MUSD 4.66 B10,300
AI-based mobile app tracks and predicts menstrual cycles.
2015London, England, United KingdomUSD 269 MUSD 275.25 M701
Smartphone-enabled glucometers and diabetes management apps are provided.
2015Delhi, Delhi, IndiaUSD 50.83 MUSD 2.74 M142
Provider of a fertility tracking app that doubles as birth control
2013Stockholm, SwedenUSD 99.5 M––
Diabetes management is enabled via glucose meters and mobile apps.
2010Palo Alto, California, United StatesUSD 201 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Impute

Premium access

Complete news archive for Impute

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Impute

Impute was founded in 2017 and raised its 1st funding round 4 years after it was founded.

Impute is headquartered in Chiyoda, Japan. It is registered at Chiyoda, Tokyo, Japan.

Impute is a funded company, having raised a total of $1.3M across 2 funding rounds to date.

Impute was founded in 2017 in Chiyoda City, Japan, within the edtech sector focused on disabilities. An AI-based app is operated to deliver cognitive training for children with Autism Spectrum Disorder, ADHD, and learning disabilities. Personalized therapy programs are created using eye-tracking and body tracking technologies. Individual assessments, customized plans, reinforced learning, and discrete trial training are included among the core services.

Impute's top competitors include Altoida, Brain in Hand and Changingday.

Impute has 4 investors. Key investors include i-nest capital, Arco Partners, TX Entrepreneur Partners, and JFC.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available